Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 113 entries
View as:

Evaluation of Hemoglobin Measurement Tools for Child Anemia Screening in Rwanda

Phase: N/A Priority: Normal
NCT ID: NCT02603250 Org: User:
Start: 09/30/15 End: 12/31/15 Due: 12/31/16

Nifty Feeding Cup Versus Generic Medicine Cup Preterm Infants Who Have Difficulty Breastfeeding

Phase: N/A Priority: Normal
NCT ID: NCT03280381 Org: User:
Start: 08/15/17 End: 09/25/18 Due: 09/25/19

Inactivated Poliovirus Vaccine (IPV) With or Without E.Coli Double Mutant Heat-Labile Toxin (dmLT) Challenge Study in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT04232943 Org: User:
Start: 01/22/20 End: 02/01/21 Due: 02/01/22

Dose Escalating Study of a Prototype CS6 Subunit Vaccine With a Modified Heat-labile Enterotoxin From Enterotoxigenic Escherichia Coli (ETEC)

Phase: N/A Priority: Normal
NCT ID: NCT03404674 Org: User:
Start: 01/16/18 End: 03/26/19 Due: 03/26/20

Study of 10-valent Pneumococcal Conjugate Vaccine (Pneumosil) Administered in a 2+1 Schedule to Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT03896477 Org: User:
Start: 07/18/19 End: 12/17/20 Due: 12/17/21

Immunogenicity of H5N1 Vaccine Following H5N2

Phase: N/A Priority: Normal
NCT ID: NCT02153671 Org: User:
Start: 05/31/14 End: 09/30/14 Due: 09/30/15

Live Attenuated Japanese Encephalitis (JE) Vaccine Coadministered With Measles Vaccine in Infants 9 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT00463684 Org: User:
Start: 07/07/07 End: 10/06/08 Due: 10/06/09

Safety Study of Inactivated Shigella Whole Cell Vaccine in Adults

Phase: N/A Priority: Normal
NCT ID: NCT01509846 Org: User:
Start: 03/31/11 End: 12/31/12 Due: 12/31/13

Safety Study of Live Attenuated Oral Shigella (WRSS1) Vaccine in Bangladeshi Adults and Children

Phase: N/A Priority: Normal
NCT ID: NCT01813071 Org: User:
Start: 08/31/13 End: 04/30/16 Due: 04/30/17

Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT02880865 Org: User:
Start: 10/13/16 End: 07/11/17 Due: 07/11/18

Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster Dose

Phase: N/A Priority: Normal
NCT ID: NCT02514746 Org: User:
Start: 07/30/15 End: 01/12/17 Due: 01/12/18

Infant Malaria Vaccine Schedule Optimization

Phase: N/A Priority: Normal
NCT ID: NCT06879327 Org: User:
Start: 05/30/25 End: 11/26/27 Due: 11/26/28

Phase 3 Trial of a Bivalent Human Papilloma Virus (HPV) Vaccine (Cecolin®) in Young Girls

Phase: N/A Priority: Normal
NCT ID: NCT04508309 Org: User:
Start: 03/15/21 End: 12/14/23 Due: 12/14/24

Ghana: The Barriers and Facilitators of Scaling up the Ellavi UBT for Postpartum Hemorrhage

Phase: N/A Priority: Normal
NCT ID: NCT05340777 Org: User:
Start: 11/18/20 End: 02/28/22 Due: 02/28/23

Study of a Novel Type 1 Oral Poliomyelitis Vaccine in Bangladesh

Phase: N/A Priority: Normal
NCT ID: NCT05644184 Org: User:
Start: 03/27/23 End: 05/15/26 Due: 05/15/27

Safety Trial of Monovalent Whole Virus Influenza (H1N1) Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT01507779 Org: User:
Start: 04/30/12 End: 12/31/12 Due: 12/31/13

Clinical Investigation Study to Evaluate the Consistency and Reproducibility of Two Consecutive Mosquito Feeding Assays

Phase: N/A Priority: Normal
NCT ID: NCT04666350 Org: User:
Start: 03/09/21 End: 12/20/21 Due: 12/20/22

Reactogenicity, Safety, and Immunogenicity of a Live Monovalent H5N2 Influenza Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT01719783 Org: User:
Start: 09/30/12 End: 01/31/13 Due: 01/31/14

Estimating the Malaria Prevention Impact of New Nets: Observational Analyses to Evaluate the Evidence Generated During Piloted New Net Distributions in Burkina Faso

Phase: N/A Priority: Normal
NCT ID: NCT04157894 Org: User:
Start: 07/07/19 End: 07/06/22 Due: 07/06/23

Pilot Safety Study to Determine the Ability of the Protector Cap Jet Injector to Prevent Cross-Contamination

Phase: N/A Priority: Normal
NCT ID: NCT00219453 Org: User:
Start: 10/31/04 End: 01/31/06 Due: 01/31/07

MaCRA Part B in Côte d'Ivoire

Phase: N/A Priority: Normal
NCT ID: NCT06804902 Org: User:
Start: 04/30/25 End: 09/30/25 Due: 09/30/26

Phase 3 Study of 10-valent Pneumococcal Conjugate Vaccine (PNEUMOSIL) in Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT03197376 Org: User:
Start: 06/21/17 End: 05/09/19 Due: 05/09/20

Evaluation of Vector and Chemoprevention-based Interventions to Reduce Malaria Burden in Urban Daaras of Touba, Senegal

Phase: N/A Priority: Normal
NCT ID: NCT06225297 Org: User:
Start: 01/19/24 End: 02/28/25 Due: 02/28/26

Targeted Antimalarial Drug Administration for Seasonal Migrant Populations in Amhara Region, Ethiopia

Phase: N/A Priority: Normal
NCT ID: NCT06516042 Org: User:
Start: 08/21/24 End: 07/31/25 Due: 07/31/26

Shigella WRSS1 Vaccine Trial in Bangladesh

Phase: N/A Priority: Normal
NCT ID: NCT02934178 Org: User:
Start: 02/23/17 End: 01/10/18 Due: 01/10/19